Altium Capital Management LP Keros Therapeutics, Inc. Transaction History

Altium Capital Management LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$26.03 - $67.04 $989,140 - $2.55 Million	-38,000 Reduced 30.16%	88,000 $2.43 Million
Q1 2022 May 16, 2022	BUY	$42.12 - $59.36 $421,200 - $593,600	10,000 Added 8.62%	126,000 $6.85 Million
Q4 2021 Feb 14, 2022	SELL	$36.95 - $62.89 $369,500 - $628,900	-10,000 Reduced 7.94%	116,000 $6.79 Million
Q3 2021 Nov 15, 2021	BUY	$29.27 - $43.71 $3.69 Million - $5.51 Million	126,000 New	126,000 $5.87 Million

153

26.7M

47.6K

34.5K

Ticker KROS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 25,757,000
Market Cap $1.18B
Description
Keros Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need. The company's lead protein therapeutic product candidate is KER-050, which is being developed ...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.